Latest News

New RSV article accepted by The Journal of Pediatrics

Ms. Mina Suh, along with colleagues within EpidStrategies (a Division of ToxStrategies), and external collaborators, has been conducting research on respiratory syncytial virus (RSV), especially as it relates to infants and children in the United States. In a prospective viral surveillance study, which was recently accepted… read more

ToxStrategies Announces New (Q)SAR Offerings

ToxStrategies is pleased to announce new quantitative structure activity relationship [(Q)SAR] service offerings, including ICH M7 pharmaceutical impurity assessments. We offer expertise in the use and interpretation of Derek Nexus and Leadscope Model Applier (LSMA) to meet guidance specifications that are essential to… read more